Canadian Urological Association / L'Association des urologues du Canada
Canadian Urological Association (CUA)
The official podcast of the Canadian Urological Association (CUA).Le podcast officiel de l'association des urologues du Canada (AUC).
Autor
Canadian Urological Association / L'Association des urologues du Canada
Categoría
Web del podcast
Último episodio
4 de mar. de 2025
¿Dónde escuchar?
Podcasts en la app Replaio Radio Muy prontoLos podcasts llegarán muy pronto a la app. Instálala ahora y sé el primero en descubrir una forma totalmente nueva de vivir los podcasts
Episodios
CUA Highlights of GU ASCO 2022 - Prostate Cancer Session - French 22.02.2022 47:07
Disclosures: Anil Kapoor Advisory Honoraria: BMS, MERCK, Ipsen, Eisai, Abbvie, Janssen, Astellas, Astra-Zeneca Speakers Bureau: Merck, Ipsen, Eisai Investments: Verity, Point Biopharma Clinical Trials: CCTG, Eisai, Janssen, Merck Leadership/Board Position Tamim Niazi Honoraria/ research funding: Abbvie, Astellas, Bayer, Janssen, Sanofi, Merck, AstraZeneca, TerSera, Knight Therapeutics, Amgen, Tolm...
CUA Highlights of GU ASCO 2022 - Kidney Cancer Session - French 22.02.2022 49:26
Disclosures: Anil Kapoor Advisory Honoraria: BMS, MERCK, Ipsen, Eisai, Abbvie, Janssen, Astellas, Astra-Zeneca Speakers Bureau: Merck, Ipsen, Eisai Investments: Verity, Point Biopharma Clinical Trials: CCTG, Eisai, Janssen, Merck Leadership/Board Position Christian Kollmannsberger Consultant: Pfizer, Merck, Sanofi, Astellas, BMS, Ipsen, Eisai, Bayer Honoraria for presentations: Pfizer, Ipsen, Eisa...
CUA Highlights of GU ASCO 2022 - Bladder Cancer Session - French 22.02.2022 42:37
Disclosures: Anil Kapoor Advisory Honoraria: BMS, MERCK, Ipsen, Eisai, Abbvie, Janssen, Astellas, Astra-Zeneca Speakers Bureau: Merck, Ipsen, Eisai Investments: Verity, Point Biopharma Clinical Trials: CCTG, Eisai, Janssen, Merck Leadership/Board Position Nimira Alimohamed Advisory Board/Consultancy roles: Pfizer, EMD Serono, Merck, Seagen Wassim Kassouf No disclosures Alejandro Berlin No disclosu...
CUA Practice Changing Publications (PCP) - Endourology (Surgical Management of BPH) 15.02.2022 58:12
Disclosures: Dean Elterman Advisory Boards/ Speakers Bureaus: Astellas, Boston Scientific, Duchesnay, Pfizer, Procept, Prodeon, Olympus, Medtronic, Urotronic, Zeneflow Kevin Zorn Advisory Board: BSCI, Procept, Zenflow
V2P2 2022 - An Update in Advanced Prostate Cancer 10.02.2022 1:01:18
Disclosures: Fred Saad Grants/Honoraria: Amgen, Astellas, AstraZeneca, Bayer, Merck, Novartis, Janssen, Myovant, Sanofi Eleni Efstathiou Research Support/P.I.: Janssen, Sanofi-Genzyme, Astellas/Medivation, Oric-Pharma, Nuvation Scientific Advisory Board/Honoraria: Janssen, Sanofi-Genzyme, Bayer, Oric Pharma, Marck, AAA-Novartis, Genetech, Astra-Zeneca, Astellas, Pfizer, Myovant
V2P2 2022 - An Update in Advanced Prostate Cancer - French 10.02.2022 1:01:18
Disclosures: Fred Saad Grants/Honoraria: Amgen, Astellas, AstraZeneca, Bayer, Merck, Novartis, Janssen, Myovant, Sanofi Eleni Efstathiou Research Support/P.I.: Janssen, Sanofi-Genzyme, Astellas/Medivation, Oric-Pharma, Nuvation Scientific Advisory Board/Honoraria: Janssen, Sanofi-Genzyme, Bayer, Oric Pharma, Marck, AAA-Novartis, Genetech, Astra-Zeneca, Astellas, Pfizer, Myovant
Practice Changing Publications (PCP): Update in Kidney Cancer 01.02.2022 1:02:32
Disclosures: Anil Kapoor Advisory Honoraria: BMS, MERCK, Ipsen, Eisai, Abbvie, Janssen, Astellas, Astra-Zeneca Speakers Bureau: Merck, Ipsen, Eisai Investments: Verity, Point Biopharma Clinical Trials: CCTG, Eisai, Janssen, Merck Leadership/Board Position: Kidney Cancer Canada Luke Lavallee Advisory Board: Sanofi, Ferring, Knight, Bayer, Janssen, Astellas Grant/Honorarium: Sanofi
The Year Ahead 2022: Global Economic Outlook 24.01.2022 57:15
Disclosures: Derek Henderson Banking relationship with TD Christopher French Advisory Boards: Astellas, AstraZeneca
Practice Changing Publications (PCP): Female Urology 07.12.2021 51:58
Disclosures: Martine Jolivet Advisory Board and/or Speaker Bureau: Allergan/Abbvie Genevieve Nadeau Clinical Trials: Contiform International Advisory Board and/or Speaker Bureau: Pfizer, Boston Scientific, Astellas, Allergan/Abbvie, Searchlight Pharma
Management of Medication-Refractory Overactive Bladder (OAB) - French 24.11.2021 1:10:05
Disclosures: Kevin Carlson Advisroy Board/Payment: Abbvie Richard Baverstock Advisory Board: Abbvie Speakers Bureau: Astellas, Boston Scientific, Abbvie Payment: Abbvie, Astellas, Bsci Greg Baily Advisory Board/ Speaker Bureau: Abbvie
Management of Medication-Refractory Overactive Bladder (OAB) 24.11.2021 1:10:11
Disclosures: Kevin Carlson Advisory Board/Payment: Abbvie Richard Baverstock Advisory Board: Abbvie Speakers Bureau: Astellas, Boston Scientific, Abbvie Payment: Abbvie, Astellas, Bsci Greg Baily Advisory Board/ Speaker Bureau: Abbvie
Precision Medicine in Prostate Cancer: Multidisciplinary Perspectives in Identifying, Managing and Optimizing Patient Care (English) 18.11.2021 1:08:51
Disclosures: Neil Fleshner Payment: Astellas, Janssen, Abbvie, Sanofi, Merck Grant/Honorarium: Astellas, Janssen, Bayer Investments: Verity Pharma Clinical Trials: Astellas, Janssen, Bayer Leadership Position: Point Biopharma Urban Emmenegger Advisory Boards: Amgen, Astellas, Bayer, Ferring, Janssen, Sanofi, Merck, AstraZeneca Payment: Astellas, Bayer, Ferring, Janssen, Sanofi, Merck, AstraZeneca...
Precision Medicine in Prostate Cancer: Multidisciplinary Perspectives in Identifying, Managing and Optimizing Patient Care (French) 17.11.2021 1:20:42
Conflits d'interests: Fred Saad Subventions/honoraires: Amgen, Astellas, AstraZeneca, Bayer, Merck, Novartis, Janssen, Myovant, Sanofi Zineb Hamilou Remuneration: AstraZeneca, Sengen, EMD Serono Essai Clinique: Sengen Evan Weber Subventions ou des honoraires: AstraZeneca/Merck
V2P2 2022 - Female Sexual Dysfunction [FR] 15.11.2021 59:33
Disclosures: Ashley Cox Advisory Board: Abbvie, Allergan Rachel S. Rubin Speakers Bureau: Sprout Clinical Trials: Ipsen, Abbvie Leadership/Board Position: ISSWSH
V2P2 2022 - Female Sexual Dysfunction 15.11.2021 59:34
Disclosures: Ashley Cox Advisory Board: Abbvie, Allergan Rachel S. Rubin Speakers Bureau: Sprout Clinical Trials: Ipsen, Abbvie Leadership/Board Position: ISSWSH
CUA Practice Changing Publications (PCP): TESTIS CANCER 02.11.2021 1:00:42
Disclosures: Armin Aprikian Advisory boards: Abbvie, Astellas, Bayer Grant/Honorarium: Abbvie, Astellas, Bayer, Sanofi, TerSera Robert Hamilton Advisory boards: Janssen, Astellas, Bayer, TerSera Clinical Trials: Janssen, Bayer, Astellas
CUA Practice Changing Publications (PCP): INFERTILITY 19.10.2021 1:03:12
Disclosures: Armand Zini Shareholder in YAD Tech - a neutraceuticals company Jesse Ory No disclosures
CUA Highlights of ESMO 2021 - Prostate Cancer Session - French 22.09.2021 48:18
Disclosures: Sebastien J. Hotte Research Funding (Institution): Astellas, AstraZeneca, Ayala, Bayer, BMS, Eisai, Exelixis, Janssen, Ipsen, Merck, Roche, Sanofi, SeaGen, SignalChem Grants (Institution): BMS, Janssen, Bayer Consultant/Honoraria (Self): Astellas, AtraZeneca ,Bayer, BMS, Eisai, Ipsen, Janssen, Merck, Pfizer, Roche, SeaGen Tamim Nizai Honoraria/Research fun: Abbvie, Sanofi, TerSera,...
CUA Highlights of ESMO 2021 - Bladder Cancer Session - French 22.09.2021 29:01
Disclosures: Girish Kilkarni Advisory Boards: Janssen, Merck, Roche, Ferring, Astellas, Theralase Grants/Honoraria: Abbvie, Sanofi, Ferring, TerSera, Knight Therapeutics, Verity Clinical Trials: Merck, Astra Zeneca, Bristol Myers Squibb, Theralase, Janssen, Pfizer Krista Noonan Consulting/Honoraria: AstraZeneca, BMS, Janssen, Merck, Pfizer, EMD Serono Research Support: Roche
CUA Highlights of ESMO 2021 - Kidney Cancer Session - French 22.09.2021 44:37
Disclosures: Michael Leveridge Ipsen - speaker session moderator 2019 Maryam Soleimani Honorarium: Pfizer Grant funding: Abbvie, Astellas, Bayer Himu Lukka No disclosures
CUA Highlights of ESMO 2021 - Kidney Cancer Session 22.09.2021 44:32
Disclosures: Michael Leveridge Ipsen - speaker session moderator 2019 Maryam Soleimani Honorarium: Pfizer Grant funding: Abbvie, Astellas, Bayer Himu Lukka No disclosures
CUA Highlights of ESMO 2021 - Bladder Cancer Session 22.09.2021 29:09
Disclosures: Girish Kilkarni Advisory Boards: Janssen, Merck, Roche, Ferring, Astellas, Theralase Grants/Honoraria: Abbvie, Sanofi, Ferring, TerSera, Knight Therapeutics, Verity Clinical Trials: Merck, Astra Zeneca, Bristol Myers Squibb, Theralase, Janssen, Pfizer Krista Noonan Consulting/Honoraria: AstraZeneca, BMS, Janssen, Merck, Pfizer, EMD Serono Research Support: Roche
CUA Highlights of ESMO 2021 - Prostate Cancer Session 22.09.2021 48:18
Disclosures: Sebastien J. Hotte Research Funding (Institution): Astellas, AstraZeneca, Ayala, Bayer, BMS, Eisai, Exelixis, Janssen, Ipsen, Merck, Roche, Sanofi, SeaGen, SignalChem Grants (Institution): BMS, Janssen, Bayer Consultant/Honoraria (Self): Astellas, AtraZeneca ,Bayer, BMS, Eisai, Ipsen, Janssen, Merck, Pfizer, Roche, SeaGen Tamim Nizai Honoraria/Research fun: Abbvie, Sanofi, TerSera,...
CUA Q & A Series | Topic: Delay of Injection 13.07.2021 26:23
Delay of Injection (Q&A series) 0:00 - Ricardo Rendon 9:30 - Fred Saad 18:10 - Jasper Yuen
Milestones in Advanced Bladder Cancer 12.07.2021 27:07
Podcast Host Disclosures: Dr. Alimohamed has had a consulting or advisory role with Astellas Pharma, AstraZeneca, Janssen, Merck, Pfizer, and Sanofi Canada. Dr. Lalani has received honoraria from Astellas Pharma, Bayer, Bristol-Myers Squibb, Merck, Novartis, Pfizer, Roche/Genentech, and TerSera; has had a consulting or advisory role with Abbvie, Astellas Pharma, Bayer, Bristol-Myers Squibb, Eisai,...
Podcasts similares
Replaio no es editor de podcasts; los nombres de los programas, las portadas y el audio pertenecen a sus autores y se distribuyen a través de canales RSS públicos